Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 8 Total
FOLD - Amicus Therapeutics Inc - Stock Price Chart
TickerFOLD [NASD, RUT]
CompanyAmicus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.76BEPS (ttm)-0.50
P/E-EPS this Y58.66%
Forward P/E42.43EPS next Y204.28%
PEG-EPS past 5Y22.84%
P/S6.53EPS next 5Y-
P/B21.14EPS Q/Q12.05%
Dividend-Sales Q/Q27.97%
Insider Own2.84%Inst Own106.43%
Insider Trans-5.70%Inst Trans-4.32%
Short Float10.00%EarningsMay 09/b
Analyst Recom1.36Target Price17.50
Avg Volume3.10M52W Range9.02 - 14.57
May-14-24Upgrade Guggenheim Neutral → Buy $13
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campbell Bradley LPresident and CEOMay 01 '24Option Exercise8.617,50064,575894,154May 03 05:21 PM
Campbell Bradley LPresident and CEOMay 01 '24Sale10.077,50075,524886,654May 03 05:21 PM
Campbell Bradley LPresident and CEOApr 01 '24Option Exercise8.617,50064,575894,154Apr 03 06:14 PM
Campbell Bradley LPresident and CEOApr 01 '24Sale11.677,50087,496886,654Apr 03 06:14 PM
SBLENDORIO GLENNDirectorMar 07 '24Option Exercise2.8015,00042,00083,596Mar 11 05:36 PM
ATO - Atmos Energy Corp. - Stock Price Chart
TickerATO [NYSE, S&P 500]
CompanyAtmos Energy Corp.
CountryUSA
IndustryUtilities - Regulated Gas
Market Cap17.69BEPS (ttm)6.67
P/E17.58EPS this Y9.15%
Forward P/E16.62EPS next Y5.94%
PEG2.34EPS past 5Y2.36%
P/S4.36EPS next 5Y7.50%
P/B1.52EPS Q/Q14.95%
Dividend2.75%Sales Q/Q6.90%
Insider Own0.35%Inst Own95.04%
Insider Trans-3.07%Inst Trans1.69%
Short Float2.54%EarningsMay 08/a
Analyst Recom2.20Target Price128.50
Avg Volume875.12K52W Range101.00 - 125.28
May-14-24Upgrade Wells Fargo Equal Weight → Overweight $130 → $132
Atmos Energy Corp. engages in the provision of natural gas services. It operates through the Distribution, and Pipeline and Storage segments. The Distribution segment is involved in regulated natural gas distribution and related sales operations. The Pipeline and Storage segment includes pipeline and storage operations of the Atmos Pipeline-Texas division and natural gas transmission operations. The company was founded in 1983 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AKERS JOHN KPRESIDENT & CEOMay 03 '24Option Exercise119.0914,2901,701,79691,672May 06 05:09 PM
Forsythe Christopher TSR VICE PRESIDENT & CFOMay 03 '24Option Exercise119.094,400523,99650,842May 06 05:16 PM
HARTSFIELD KAREN ESR VP, GC & CORPORATE SEC'YMay 03 '24Option Exercise119.093,215382,87424,904May 06 05:17 PM
ROBBINS J MATTSR VP, HUMAN RESOURCESMay 03 '24Option Exercise119.093,215382,87422,306May 06 05:21 PM
MCDILL JOHN SSR VP, UTILITY OPERATIONSMay 03 '24Option Exercise119.091,600190,54427,538May 06 05:20 PM
EW - Edwards Lifesciences Corp - Stock Price Chart
TickerEW [NYSE, S&P 500]
CompanyEdwards Lifesciences Corp
CountryUSA
IndustryMedical Devices
Market Cap52.10BEPS (ttm)2.33
P/E37.16EPS this Y10.43%
Forward P/E27.77EPS next Y12.34%
PEG3.94EPS past 5Y15.35%
P/S8.48EPS next 5Y9.44%
P/B7.32EPS Q/Q4.50%
Dividend-Sales Q/Q9.50%
Insider Own1.61%Inst Own83.23%
Insider Trans-4.18%Inst Trans-0.08%
Short Float1.62%EarningsApr 25/a
Analyst Recom2.03Target Price96.55
Avg Volume3.38M52W Range60.57 - 96.12
May-14-24Upgrade Deutsche Bank Hold → Buy
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 10 '24Option Exercise45.285,000226,38452,750May 13 05:45 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 10 '24Sale87.815,000439,03847,750May 13 05:45 PM
Lippis Daniel J.CVP, JAPACMay 07 '24Option Exercise36.7585731,49525,333May 09 07:40 PM
Lippis Daniel J.CVP, JAPACMay 07 '24Sale85.6085773,35923,890May 09 07:40 PM
Zovighian Bernard JCEOMay 06 '24Buy85.7458049,7533,268May 07 05:53 PM
EHAB - Enhabit Inc - Stock Price Chart
TickerEHAB [NYSE, RUT]
CompanyEnhabit Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap453.45MEPS (ttm)-1.67
P/E-EPS this Y19.64%
Forward P/E25.97EPS next Y32.24%
PEG-EPS past 5Y-
P/S0.43EPS next 5Y-
P/B0.68EPS Q/Q-92.58%
Dividend-Sales Q/Q-1.02%
Insider Own12.24%Inst Own101.84%
Insider Trans0.15%Inst Trans-
Short Float6.95%EarningsMay 08/a
Analyst Recom3.12Target Price9.32
Avg Volume632.49K52W Range7.12 - 14.59
May-14-24Upgrade Leerink Partners Underperform → Market Perform $8.50
Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bolton JeffreyDirectorMay 10 '24Buy8.2410,00082,40042,299May 10 05:27 PM
Langham Ronald Leroy JREVP Clinical Excel. & StrategyMar 01 '24Sale8.816345,58657,164Mar 05 05:48 PM
Bolton JeffreyDirectorMay 26 '23Buy11.612,00023,22019,597May 31 08:17 PM
SHAW L EDWARD JRDirectorMay 22 '23Buy11.9810,000119,80038,989May 23 05:50 PM
Langham Ronald Leroy JREVP Clinical Excel. & StrategyMay 18 '23Buy11.9910,000119,90044,328May 22 09:48 AM
EXPD - Expeditors International Of Washington, Inc. - Stock Price Chart
TickerEXPD [NYSE, S&P 500]
CompanyExpeditors International Of Washington, Inc.
CountryUSA
IndustryIntegrated Freight & Logistics
Market Cap16.60BEPS (ttm)4.72
P/E24.91EPS this Y-3.51%
Forward P/E22.80EPS next Y6.61%
PEG-EPS past 5Y7.60%
P/S1.86EPS next 5Y-
P/B7.55EPS Q/Q-19.27%
Dividend1.34%Sales Q/Q-14.89%
Insider Own0.71%Inst Own99.97%
Insider Trans-0.60%Inst Trans0.02%
Short Float4.71%EarningsMay 07/b
Analyst Recom3.76Target Price109.50
Avg Volume1.30M52W Range107.03 - 131.17
May-14-24Upgrade Exane BNP Paribas Underperform → Neutral $112
Expeditors International of Washington, Inc. engages in the provision of global logistics services. The firm offers air freight, ocean freight and ocean and customs brokerage and other services. It also provides customer solutions such as order management, time-definite transportation, warehousing and distribution, temperature-controlled transit, cargo insurance and customized logistics solutions. The company was founded by John M. Kaiser, Peter Rose, Wang Li Kou, Kevin Walsh, Hank Wong, George Ho, Robert Chiarito, and Glenn Alger in 1979 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bell Blake RPresident, Global ServicesMay 08 '24Sale116.994,100479,65952,745May 10 01:48 PM
Bell Blake RPresident, Global ServicesMay 03 '24Option Exercise0.001,323057,093May 07 03:39 PM
Blacker Kelly KPresident, Global ProductsMay 03 '24Option Exercise0.001,65308,076May 07 03:43 PM
Clark Benjamin G.SVP - Chief Strategy OfficerMay 03 '24Option Exercise0.001,653020,994May 07 03:47 PM
Dickerman Jeffrey FSenior VP/Gen Counsel/Corp SecMay 03 '24Option Exercise0.001,65307,508May 07 03:51 PM
XPRO - Expro Group Holdings N.V. - Stock Price Chart
TickerXPRO [NYSE, RUT]
CompanyExpro Group Holdings N.V.
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap2.32BEPS (ttm)-0.18
P/E-EPS this Y498.81%
Forward P/E16.15EPS next Y55.22%
PEG-EPS past 5Y38.49%
P/S1.49EPS next 5Y-
P/B1.77EPS Q/Q58.32%
Dividend-Sales Q/Q13.03%
Insider Own4.45%Inst Own89.28%
Insider Trans0.00%Inst Trans5.22%
Short Float5.99%EarningsApr 25/b
Analyst Recom1.67Target Price24.83
Avg Volume814.72K52W Range14.33 - 25.04
May-14-24Upgrade Barclays Equal Weight → Overweight $18 → $27
Expro Group Holdings NV engages in the provision of energy services. It operates through the following geographical segments: North and Latin America (NLA), Europe and Sub-Saharan Africa (ESSA), Middle East and North Africa (MENA), and Asia-Pacific (APAC). The company was founded in 1938 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KEARNEY MICHAEL CDirectorSep 15 '23Sale24.1615,400372,09327,633Sep 15 04:05 PM
Drummond Robert Wayne JrDirectorSep 15 '23Sale24.1913,000314,51643,433Sep 15 04:07 PM
OAK HILL ADVISORS LP10% OwnerSep 14 '23Sale22.953,000,00068,865,00014,575,891Sep 18 04:05 PM
KEARNEY MICHAEL CDirectorSep 13 '23Sale23.842,60061,98443,033Sep 13 05:13 PM
KEARNEY MICHAEL CDirectorSep 06 '23Sale24.445,735140,15745,633Sep 07 04:54 PM
SRPT - Sarepta Therapeutics Inc - Stock Price Chart
TickerSRPT [NASD]
CompanySarepta Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap12.54BEPS (ttm)0.07
P/E1994.89EPS this Y156.76%
Forward P/E13.28EPS next Y203.34%
PEG-EPS past 5Y-1.21%
P/S8.94EPS next 5Y-
P/B13.04EPS Q/Q106.22%
Dividend-Sales Q/Q63.10%
Insider Own5.86%Inst Own85.56%
Insider Trans-0.50%Inst Trans6.35%
Short Float6.40%EarningsMay 01/a
Analyst Recom1.38Target Price168.30
Avg Volume922.49K52W Range55.25 - 159.89
May-14-24Upgrade Oppenheimer Perform → Outperform $180
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murray DallanChief Customer OfficerMay 02 '24Sale140.003,635508,90018,125May 06 08:09 PM
Boor Kathryn JeanDirectorMar 11 '24Sale122.9376193,5507,516Mar 11 08:00 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Option Exercise13.9015,000208,50037,840Mar 11 08:02 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Sale123.2515,0001,848,79522,840Mar 11 08:02 PM
Mayo StephenDirectorMar 05 '24Sale122.963,135385,4806,621Mar 06 08:00 PM
VTEX - Vtex - Stock Price Chart
TickerVTEX [NYSE]
CompanyVtex
CountryUnited Kingdom
IndustrySoftware - Application
Market Cap1.35BEPS (ttm)0.00
P/E-EPS this Y124.04%
Forward P/E46.96EPS next Y788.11%
PEG-EPS past 5Y76.52%
P/S6.37EPS next 5Y-
P/B5.55EPS Q/Q-
Dividend-Sales Q/Q24.52%
Insider Own72.26%Inst Own17.58%
Insider Trans0.00%Inst Trans-7.17%
Short Float0.27%EarningsMay 07/a
Analyst Recom1.29Target Price10.33
Avg Volume547.05K52W Range3.76 - 9.59
May-14-24Upgrade JP Morgan Neutral → Overweight $9
VTEX provides software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables its customers to execute its commerce strategy, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third- party vendors. The company was founded by Geraldo do Carmo Thomaz Junior and Mariano Gomide de Faria in 2000 and is headquartered in London, the United Kingdom.
1